Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Return on Assets: 2019-2025

Historic Return on Assets for Eton Pharmaceuticals (ETON) over the last 6 years, with Sep 2025 value amounting to -0.06%.

  • Eton Pharmaceuticals' Return on Assets rose 10.00% to -0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.06%, marking a year-over-year increase of 10.00%. This contributed to the annual value of -0.07% for FY2024, which is 4.00% down from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Return on Assets stood at -0.06%, which was down 45.79% from -0.04% recorded in Q2 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Return on Assets peaked at 0.07% during Q3 2023, and registered a low of -0.52% during Q2 2022.
  • For the 3-year period, Eton Pharmaceuticals' Return on Assets averaged around -0.07%, with its median value being -0.06% (2025).
  • As far as peak fluctuations go, Eton Pharmaceuticals' Return on Assets surged by 141bps in 2021, and later crashed by 32bps in 2022.
  • Over the past 5 years, Eton Pharmaceuticals' Return on Assets (Quarterly) stood at -0.07% in 2021, then plummeted by 32bps to -0.39% in 2022, then skyrocketed by 36bps to -0.03% in 2023, then declined by 4bps to -0.07% in 2024, then grew by 10bps to -0.06% in 2025.
  • Its last three reported values are -0.06% in Q3 2025, -0.04% for Q2 2025, and -0.06% during Q1 2025.